| Richard F Rinehardt, MD | |
|
1603 Skipwith Rd, Henrico, VA 23229-5253 | |
| (804) 507-1644 | |
| (804) 507-0116 |
| Full Name | Richard F Rinehardt |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 1603 Skipwith Rd, Henrico, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639154842 | NPI | - | NPPES |
| 1639154842 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0101043195 (Virginia) | Primary |
| Entity Name | Virginia Physicians For Women, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639137979 PECOS PAC ID: 8628057924 Enrollment ID: O20040720000074 |
News Archive
AIDS endures right here in the U.S.A.: our outpatient clinics are bursting at the seams, and new cases show up daily. A million domestic stories are languishing untold, but they are not the operatic tragedies we have grown used to (Dr. Abigail Zuger, 4/19).
What if our immune system could cure cancer? This logic seems almost too simple to be true, but it forms the basis of an emerging cancer treatment—immunotherapy.
A Saint Louis University research paper published online March 16 in JMIR Mental Health explores the feasibility of helping low-income mothers through postpartum depression using text messages.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the first patient has been dosed in its expanded Phase I/II trial of its affinity enhanced T-cell receptor therapeutic targeting the NY-ESO-1 cancer antigen in synovial sarcoma patients.
IMRIS Inc. today announced that the Company has received Health Canada licensing to incorporate next generation MRI core technology into the VISIUS Surgical Theatre for sales and marketing in the country.
› Verified 2 days ago
| Entity Name | Dominion Women's Health, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932289592 PECOS PAC ID: 1456327824 Enrollment ID: O20040907001241 |
News Archive
AIDS endures right here in the U.S.A.: our outpatient clinics are bursting at the seams, and new cases show up daily. A million domestic stories are languishing untold, but they are not the operatic tragedies we have grown used to (Dr. Abigail Zuger, 4/19).
What if our immune system could cure cancer? This logic seems almost too simple to be true, but it forms the basis of an emerging cancer treatment—immunotherapy.
A Saint Louis University research paper published online March 16 in JMIR Mental Health explores the feasibility of helping low-income mothers through postpartum depression using text messages.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the first patient has been dosed in its expanded Phase I/II trial of its affinity enhanced T-cell receptor therapeutic targeting the NY-ESO-1 cancer antigen in synovial sarcoma patients.
IMRIS Inc. today announced that the Company has received Health Canada licensing to incorporate next generation MRI core technology into the VISIUS Surgical Theatre for sales and marketing in the country.
› Verified 2 days ago
| Entity Name | Obhg Virginia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972807394 PECOS PAC ID: 9436323342 Enrollment ID: O20111110000430 |
News Archive
AIDS endures right here in the U.S.A.: our outpatient clinics are bursting at the seams, and new cases show up daily. A million domestic stories are languishing untold, but they are not the operatic tragedies we have grown used to (Dr. Abigail Zuger, 4/19).
What if our immune system could cure cancer? This logic seems almost too simple to be true, but it forms the basis of an emerging cancer treatment—immunotherapy.
A Saint Louis University research paper published online March 16 in JMIR Mental Health explores the feasibility of helping low-income mothers through postpartum depression using text messages.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the first patient has been dosed in its expanded Phase I/II trial of its affinity enhanced T-cell receptor therapeutic targeting the NY-ESO-1 cancer antigen in synovial sarcoma patients.
IMRIS Inc. today announced that the Company has received Health Canada licensing to incorporate next generation MRI core technology into the VISIUS Surgical Theatre for sales and marketing in the country.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard F Rinehardt, MD Po Box 7650, Henrico, VA 23231-0150 Ph: (804) 507-1644 | Richard F Rinehardt, MD 1603 Skipwith Rd, Henrico, VA 23229-5253 Ph: (804) 507-1644 |
News Archive
AIDS endures right here in the U.S.A.: our outpatient clinics are bursting at the seams, and new cases show up daily. A million domestic stories are languishing untold, but they are not the operatic tragedies we have grown used to (Dr. Abigail Zuger, 4/19).
What if our immune system could cure cancer? This logic seems almost too simple to be true, but it forms the basis of an emerging cancer treatment—immunotherapy.
A Saint Louis University research paper published online March 16 in JMIR Mental Health explores the feasibility of helping low-income mothers through postpartum depression using text messages.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the first patient has been dosed in its expanded Phase I/II trial of its affinity enhanced T-cell receptor therapeutic targeting the NY-ESO-1 cancer antigen in synovial sarcoma patients.
IMRIS Inc. today announced that the Company has received Health Canada licensing to incorporate next generation MRI core technology into the VISIUS Surgical Theatre for sales and marketing in the country.
› Verified 2 days ago
Robert P Mcbride Iii, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1603 Skipwith Rd, Henrico, VA 23229 Phone: 804-507-1644 Fax: 804-507-0116 | |
Anne Judith Soucy, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5606 Staples Mill Rd, Henrico, VA 23228 Phone: 804-525-5039 Fax: 804-834-7650 | |
Nicole C Rankins, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1603 Skipwith Rd, Henrico, VA 23229 Phone: 804-507-1644 Fax: 804-507-0116 | |
Anna Baur, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7605 Forest Ave Ste 411, Henrico, VA 23229 Phone: 042-858-8806 Fax: 804-288-6079 | |
Jacqueline Platamone, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 12129 Graham Meadows Dr, Henrico, VA 23233 Phone: 804-288-4084 Fax: 804-282-2601 | |
Jessica L Vantuyle, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1603 Skipwith Rd, Henrico, VA 23229 Phone: 804-507-1644 Fax: 804-507-0116 |